Navigation Links
Van Andel Institute Research Symposium Showcases Latest Developments In Parkinson's Research
Date:9/20/2012

GRAND RAPIDS, Mich., Sept. 20, 2012 /PRNewswire/ -- Van Andel Institute (VAI) hosts a scientific symposium September 19-20 that gathers some of the world's most noted experts in Parkinson's disease and reinforces the region's growing reputation in the field of Parkinson's research.

Grand Challenges in Parkinson's Disease features experts from a dozen nations including Australia, Malaysia and Sweden. The purpose of the event is to showcase the latest research in the field and to honor Andrew B. Singleton, Ph.D., of the National Institutes of Health (NIH) with the first Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research.

"This is truly a gathering of some of the world's greatest minds in Parkinson's disease research," said chief event organizer Patrik Brundin, M.D., Ph.D., Chair of the Jay Van Andel Translational Parkinson's Disease Research Laboratory and Director of Van Andel Institute's Center for Neurodegenerative Science. "We will be sharing the results of recent and ongoing research that will become the building blocks for therapies that may be commonplace a decade from now."

The event features keynote addresses by noted Parkinson's experts Ted Dawson, M.D., Ph.D., of The Johns Hopkins University, who will speak on the topic of Looking Forward to Tomorrow's Therapies for Parkinson's Disease, and Roger Barker, Ph.D., of University of Cambridge, who will speak on Matching Therapies to Patients: The Complexities of Disease Heterogeneity in Parkinson's Disease.

Dr. Andrew Singleton is best known for his work aimed at understanding the genetic causes of Parkinson's disease – work that is opening entire new fields of research.

His first well-known work described the discovery of a duplication and triplication of the alpha-synuclein gene that causes a severe, early-onset form of Parkinson's disease. Scientists already knew that a few extremely rare mutant forms of the protein were bad, but Dr. Singleton showed that too much of the normal protein also has ramifications.

One year later he led the group that was the first to identify mutations in the LRRK2 gene as a cause of familial Parkinson's disease. Occasionally new mutations arise in this gene, which can explain some of the cases of the more common, sporadic Parkinson's disease.

For more information, please visit www.vai.org


'/>"/>
SOURCE Van Andel Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
2. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
3. Candelis and Microsoft Team Up to Empower Patients
4. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
5. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
6. Scripps Research Institute scientists find easier way to make new drug compounds
7. Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
8. West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
9. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
10. Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
11. The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.s Technology in Combating Colony Collapse Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... three states, announced today the promotion of two long-standing principal investigators (PI) to ... Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark Research ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing genomic ... for Microsoft Azure from major institutions collecting and analyzing genomic data,” said Adam ...
(Date:2/9/2016)... 2016  Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to ... recently reported the Company,s operating results for 2015 ... Lonza America , Inc. (the "Lonza ... in the process of consummating an agreement to ...
(Date:2/9/2016)... ... February 09, 2016 , ... The American Academy of Thermology ... offering its 2016 AAT Member Certification Qualification Course for Technicians via a two part ... which will include a detailed review of hardware, software, and camera setup/operations, aligns with ...
Breaking Biology Technology:
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/25/2016)... Pa. , Jan. 25, 2016   Unisys Corporation ... system at John F. Kennedy (JFK) International Airport, New ... Protection (CBP) identify imposters attempting to enter the ... not belong to them. pilot testing of the ... initially at three terminals at JFK during January 2016. --> ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
Breaking Biology News(10 mins):